RUO urelumab是一種靶向4-1BB的人源化激動性單克隆抗體,具有潛在的免疫刺激和抗腫瘤活性。Urelumab特異性結合并激活表達CD 137的免疫細胞,刺激針對腫瘤細胞的免疫應答,特別是細胞毒性T細胞應答。. Urelumab生物仿制藥-研究級該產品同種型對照:Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.